Methylene Blue for Treatment of Hospitalized COVID-19 Patients, Randomized, Controlled, Open-Label Clinical Trial, Phase 3
| dc.contributor.author | Hamidi Alamdari, Daryoush | |
| dc.contributor.author | Hafizi Lotfabadi, Saied | |
| dc.contributor.author | Mavaji Darban, Behzad | |
| dc.contributor.author | Agheli-Rad, Marzieh | |
| dc.contributor.author | Saadatian, Shahin | |
| dc.contributor.author | Hashemi, Seyed Hadi | |
| dc.contributor.author | Barazandeh Ahmadabadi, Fatemeh | |
| dc.contributor.author | Morovatdar, Negar | |
| dc.contributor.author | Arastoo, Mohammad | |
| dc.contributor.author | Bhushan, Bharat | |
| dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
| dc.date.accessioned | 2021-07-16T19:01:01Z | |
| dc.date.available | 2021-07-16T19:01:01Z | |
| dc.date.issued | 2021 | |
| dc.description | Funding: This work was supported by a grant from Mashhad University of Medical Sciences (Grant number: 990096, 990845). Acknowledgements: The authors gratefully acknowledge the nurses in Iamm Reza Hospital, Shariati Hospital, Hasheminejad Hospital for their excellent cooperation. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 7 | |
| dc.format.extent | 493987 | |
| dc.identifier | 197056006 | |
| dc.identifier | 61565c11-e3b0-4e62-8cbd-80d484f723ba | |
| dc.identifier.citation | Hamidi Alamdari, D, Hafizi Lotfabadi, S, Mavaji Darban, B, Agheli-Rad, M, Saadatian, S, Hashemi, S H, Barazandeh Ahmadabadi, F, Morovatdar, N, Arastoo, M & Bhushan, B 2021, 'Methylene Blue for Treatment of Hospitalized COVID-19 Patients, Randomized, Controlled, Open-Label Clinical Trial, Phase 3', Aristotle Biomedical Journal, vol. 3, no. 2, pp. 12-18. < https://ejournals.lib.auth.gr/ABJ/article/view/8158/7922 > | en |
| dc.identifier.iss | 2 | en |
| dc.identifier.issn | 2653-9748 | |
| dc.identifier.other | ORCID: /0000-0002-0805-4949/work/97287775 | |
| dc.identifier.uri | https://hdl.handle.net/2164/16825 | |
| dc.identifier.url | https://ejournals.lib.auth.gr/ABJ/article/view/8158/7922 | en |
| dc.identifier.vol | 3 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Aristotle Biomedical Journal | en |
| dc.subject | COVID-19 | en |
| dc.subject | Treatment | en |
| dc.subject | Methylene Blue | en |
| dc.subject | Mortality | en |
| dc.subject | R Medicine | en |
| dc.subject.lcc | R | en |
| dc.title | Methylene Blue for Treatment of Hospitalized COVID-19 Patients, Randomized, Controlled, Open-Label Clinical Trial, Phase 3 | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Alamdari_etal_ABJ_Methylene_blue_for_VOR.pdf
- Size:
- 482.41 KB
- Format:
- Adobe Portable Document Format
